Eris Lifesciences Ltd.

1,328.20.17%

2026-08-21

eris.co.inBSE: 540596NSE: ERIS
Market Cap₹ 18,683 Cr.
Current Price₹ 1,326
High / Low₹ 1,819 / 1,200
Stock P/E29.0
Book Value₹ 292
Price to Book6.78
Dividend Yield0.53 %
ROCE13.6 %
ROE13.8 %
Face Value₹ 1

Add ratio to table

ABOUT

KEY POINTS

PROS

  • Company has consistently been profitable over the last 5 years
  • Company has delivered good sales growth of 21.9% CAGR over last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.61x)

CONS

  • Company has delivered a poor profit growth of 4.8% over past five years
  • Stock is trading at 6.8x its book value

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

EDIT COLUMNS
S.No.NameCMP Rs.P/EMar Cap Rs.Cr.Div Yld %NP Qtr Rs.Cr.Qtr Profit Var %Sales Qtr Rs.Cr.Qtr Sales Var %ROCE %OPM %
1.SUNPHARMA1898.0037.65455393.780.842901.2326.5315299.8810.9819.1128.81
2.DIVISLAB8525.0077.37226311.960.35902.0065.503080.0027.8021.5140.75
3.TORNTPHARM5013.0087.43190678.410.76566.003.284921.0057.3219.2733.81
4.CIPLA1416.0033.94114392.010.92785.55-39.187119.284.1316.0016.73
5.ZYDUSLIFE1105.0024.42110224.170.09990.20-34.908017.0023.9721.3924.54
6.LUPIN2220.0018.36101506.150.811416.9816.018276.8934.2828.8629.59
7.MANKIND2391.0048.3498747.340.04574.0929.124030.5912.8913.2426.30
8.DRREDDY1171.0030.3397740.540.68435.60-69.108099.80-5.2113.7510.63
9.LAURUSLABS1807.0089.3097634.420.113620.702139.4220263.101191.0018.2031.50
10.AUROPHARMA1615.1525.0392932.160.251032.0325.229150.3517.4412.7620.54
11.BIOCON414.30136.3267518.230.12136.8053.364336.0010.893.2619.54
12.ERIS1348.1529.0218683.110.53143.3214.56873.2513.1813.5933.88
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Jun 2023
460
297
Operating Profit
OPM %
Other Income
1
Interest
17
Depreciation
41
112
Tax %
16.75%
Net Profit
0
7
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Sep 2023
501
324
Operating Profit
OPM %
Other Income
3
Interest
16
Depreciation
42
126
Tax %
3.11%
Net Profit
0
9
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Dec 2023
483
311
Operating Profit
OPM %
Other Income
4
Interest
18
Depreciation
46
116
Tax %
12.44%
Net Profit
0
8
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Mar 2024
547
403
Operating Profit
OPM %
Other Income
15
Interest
33
Depreciation
54
77
Tax %
-3.86%
Net Profit
0
5
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Jun 2024
716
470
Operating Profit
OPM %
Other Income
2
Interest
60
Depreciation
76
116
Tax %
22.48%
Net Profit
89
6
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Sep 2024
739
477
Operating Profit
OPM %
Other Income
5
Interest
59
Depreciation
80
129
Tax %
25.39%
Net Profit
96
7
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Dec 2024
722
477
Operating Profit
OPM %
Other Income
4
Interest
57
Depreciation
81
116
Tax %
25.18%
Net Profit
87
6
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Mar 2025
703
453
Operating Profit
OPM %
Other Income
8
Interest
54
Depreciation
77
129
Tax %
20.59%
Net Profit
102
7
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Jun 2025
772
496
Operating Profit
OPM %
Other Income
3
Interest
49
Depreciation
71
160
Tax %
22.47%
Net Profit
125
9
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Sep 2025
790
504
Operating Profit
OPM %
Other Income
3
Interest
50
Depreciation
69
172
Tax %
22.16%
Net Profit
134
9
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Dec 2025
801
526
Operating Profit
OPM %
Other Income
0
Interest
49
Depreciation
70
145
Tax %
25.15%
Net Profit
109
7
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Mar 2026
752
483
Operating Profit
OPM %
Other Income
2
Interest
46
Depreciation
70
161
Tax %
-74.52%
Net Profit
279
21
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Jun 2026
873
696
Operating Profit
OPM %
Other Income
2
Interest
47
Depreciation
72
179
Tax %
20.15%
Net Profit
143
1
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%
Equity Capital
14
Reserves
0
Promoter Pledge %
0.00%

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016
597
425
Operating Profit
175
OPM %
29
Other Income
3
Interest
0
Depreciation
20
154
Tax %
13
Net Profit
135
EPS
9,714
Dividend Payout %
62
Minority Interest
-1
Share of Associates
0
Adjusted EPS
10
Minority Interest
-1
Share of Associates
0
Adjusted EPS
10
Mar 2017
749
480
Operating Profit
294
OPM %
39
Other Income
25
Interest
1
Depreciation
23
270
Tax %
9
Net Profit
247
EPS
18
Dividend Payout %
0
Minority Interest
0
Share of Associates
0
Adjusted EPS
18
Minority Interest
0
Share of Associates
0
Adjusted EPS
18
Mar 2018
856
533
Operating Profit
349
OPM %
41
Other Income
26
Interest
11
Depreciation
26
312
Tax %
6
Net Profit
295
EPS
21
Dividend Payout %
0
Minority Interest
-1
Share of Associates
0
Adjusted EPS
21
Minority Interest
-1
Share of Associates
0
Adjusted EPS
21
Mar 2019
982
637
Operating Profit
377
OPM %
38
Other Income
32
Interest
23
Depreciation
36
317
Tax %
8
Net Profit
291
EPS
21
Dividend Payout %
0
Minority Interest
-0
Share of Associates
0
Adjusted EPS
21
Minority Interest
-0
Share of Associates
0
Adjusted EPS
21
Mar 2020
1,074
706
Operating Profit
384
OPM %
36
Other Income
16
Interest
2
Depreciation
50
331
Tax %
11
Net Profit
297
EPS
22
Dividend Payout %
13
Minority Interest
-0
Share of Associates
0
Adjusted EPS
22
Minority Interest
-0
Share of Associates
0
Adjusted EPS
22
Mar 2021
1,212
781
Operating Profit
439
OPM %
36
Other Income
9
Interest
2
Depreciation
43
394
Tax %
10
Net Profit
355
EPS
26
Dividend Payout %
21
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Minority Interest
0
Share of Associates
0
Adjusted EPS
26
Mar 2022
1,347
862
Operating Profit
511
OPM %
38
Other Income
26
Interest
4
Depreciation
65
442
Tax %
8
Net Profit
406
EPS
30
Dividend Payout %
20
Minority Interest
0
Share of Associates
0
Adjusted EPS
30
Minority Interest
0
Share of Associates
0
Adjusted EPS
30
Mar 2023
1,685
1,148
Operating Profit
548
OPM %
33
Other Income
11
Interest
26
Depreciation
117
405
Tax %
8
Net Profit
374
EPS
28
Dividend Payout %
26
Minority Interest
8
Share of Associates
0
Adjusted EPS
28
Minority Interest
8
Share of Associates
0
Adjusted EPS
28
Mar 2024
2,009
1,334
Operating Profit
699
OPM %
35
Other Income
24
Interest
85
Depreciation
183
431
Tax %
8
Net Profit
397
EPS
29
Dividend Payout %
0
Minority Interest
-5
Share of Associates
0
Adjusted EPS
29
Minority Interest
-5
Share of Associates
0
Adjusted EPS
29
Mar 2025
2,894
1,876
Operating Profit
1,036
OPM %
36
Other Income
18
Interest
231
Depreciation
315
489
Tax %
23
Net Profit
375
EPS
26
Dividend Payout %
28
Minority Interest
-23
Share of Associates
0
Adjusted EPS
26
Minority Interest
-23
Share of Associates
0
Adjusted EPS
26
TTM
3,217
2,209
Operating Profit
OPM %
Other Income
7
Interest
191
Depreciation
281
658
Tax %
-1
Net Profit
667
EPS
Dividend Payout %
Minority Interest
1
Share of Associates
-1
Adjusted EPS
Minority Interest
1
Share of Associates
-1
Adjusted EPS

COMPOUNDED SALES GROWTH

10 Years:
18%
5 Years:
22%
3 Years:
29%

COMPOUNDED PROFIT GROWTH

10 Years:
15%
5 Years:
3%
3 Years:
-5%

STOCK PRICE CAGR

10 Years:
5 Years:
13%
3 Years:
16%
1 Year:
-24%

RETURN ON EQUITY

10 Years:
30%
5 Years:
19%
3 Years:
16%
Last Year:
14%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

2026

May 29

₹ 7.21

Rs.7.2100 per share(721%)Interim Dividend

2025

Feb 13

₹ 7.35

Interim Dividend

2022

Aug 11

₹ 7.35

Interim Dividend

2021

Aug 5

₹ 6.01

Interim Dividend

Mar 2016
Equity Capital
0
299
0
Trade Payables
25
67
Total Liabilities
392
71
Capital Work in Progress
0
190
48
0
Cash & Bank
10
73
Total Assets
392
Total Debt
0
Net Working Capital
153
Contingent Liabilities
1
Book Value per Share
21711.81
Face Value
10.00
Total Debt
0
Net Working Capital
153
Contingent Liabilities
1
Book Value per Share
21711.81
Face Value
10.00
Mar 2017
Equity Capital
14
553
0
Trade Payables
39
126
Total Liabilities
732
232
Capital Work in Progress
0
303
56
0
Cash & Bank
2
139
Total Assets
732
Total Debt
1
Net Working Capital
140
Contingent Liabilities
13
Book Value per Share
41.25
Face Value
1.00
Total Debt
1
Net Working Capital
140
Contingent Liabilities
13
Book Value per Share
41.25
Face Value
1.00
Mar 2018
Equity Capital
14
848
103
Trade Payables
91
373
Total Liabilities
1,428
771
Capital Work in Progress
0
365
65
0
Cash & Bank
11
215
Total Assets
1,428
Total Debt
377
Net Working Capital
73
Contingent Liabilities
14
Book Value per Share
62.64
Face Value
1.00
Total Debt
377
Net Working Capital
73
Contingent Liabilities
14
Book Value per Share
62.64
Face Value
1.00
Mar 2019
Equity Capital
14
1,136
176
Trade Payables
84
71
Total Liabilities
1,481
761
Capital Work in Progress
1
356
83
0
Cash & Bank
8
273
Total Assets
1,481
Total Debt
176
Net Working Capital
276
Contingent Liabilities
17
Book Value per Share
83.57
Face Value
1.00
Total Debt
176
Net Working Capital
276
Contingent Liabilities
17
Book Value per Share
83.57
Face Value
1.00
Mar 2020
Equity Capital
14
1,280
0
Trade Payables
100
43
Total Liabilities
1,437
875
Capital Work in Progress
0
78
69
0
Cash & Bank
67
347
Total Assets
1,437
Total Debt
0
Net Working Capital
315
Contingent Liabilities
17
Book Value per Share
95.26
Face Value
1.00
Total Debt
0
Net Working Capital
315
Contingent Liabilities
17
Book Value per Share
95.26
Face Value
1.00
Mar 2021
Equity Capital
14
1,559
0
Trade Payables
103
28
Total Liabilities
1,703
854
Capital Work in Progress
0
294
94
0
Cash & Bank
38
422
Total Assets
1,703
Total Debt
0
Net Working Capital
300
Contingent Liabilities
20
Book Value per Share
115.81
Face Value
1.00
Total Debt
0
Net Working Capital
300
Contingent Liabilities
20
Book Value per Share
115.81
Face Value
1.00
Mar 2022
Equity Capital
14
1,893
0
Trade Payables
118
89
Total Liabilities
2,113
918
Capital Work in Progress
24
520
118
0
Cash & Bank
52
480
Total Assets
2,113
Total Debt
45
Net Working Capital
428
Contingent Liabilities
25
Book Value per Share
140.25
Face Value
1.00
Total Debt
45
Net Working Capital
428
Contingent Liabilities
25
Book Value per Share
140.25
Face Value
1.00
Mar 2023
Equity Capital
14
2,180
55
Trade Payables
125
1,099
Total Liabilities
3,472
2,568
Capital Work in Progress
21
37
131
0
Cash & Bank
58
656
Total Assets
3,472
Total Debt
830
Net Working Capital
321
Contingent Liabilities
28
Book Value per Share
161.28
Face Value
1.00
Total Debt
830
Net Working Capital
321
Contingent Liabilities
28
Book Value per Share
161.28
Face Value
1.00
Mar 2024
Equity Capital
14
2,568
1,749
Trade Payables
219
2,262
Total Liabilities
6,810
4,319
Capital Work in Progress
19
16
189
422
Cash & Bank
1,401
445
Total Assets
6,810
Total Debt
2,735
Net Working Capital
-230
Contingent Liabilities
54
Book Value per Share
189.79
Face Value
1.00
Total Debt
2,735
Net Working Capital
-230
Contingent Liabilities
54
Book Value per Share
189.79
Face Value
1.00
Mar 2025
Equity Capital
14
2,831
397
Trade Payables
332
3,289
Total Liabilities
6,862
5,306
Capital Work in Progress
67
67
335
459
Cash & Bank
223
406
Total Assets
6,862
Total Debt
2,422
Net Working Capital
-158
Contingent Liabilities
64
Book Value per Share
208.83
Face Value
1.00
Total Debt
2,422
Net Working Capital
-158
Contingent Liabilities
64
Book Value per Share
208.83
Face Value
1.00

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016
131
Cash from Investing
-44
Cash from Financing
-84
4
Free Cash Flow
112
OCF / Net Profit
0.97
Cumulative 5-Year FCF
0
OCF / Net Profit
0.97
Cumulative 5-Year FCF
0
Mar 2017
200
Cash from Investing
-184
Cash from Financing
-24
-8
Free Cash Flow
69
OCF / Net Profit
0.81
Cumulative 5-Year FCF
0
OCF / Net Profit
0.81
Cumulative 5-Year FCF
0
Mar 2018
235
Cash from Investing
-590
Cash from Financing
363
8
Free Cash Flow
-330
OCF / Net Profit
0.80
Cumulative 5-Year FCF
0
OCF / Net Profit
0.80
Cumulative 5-Year FCF
0
Mar 2019
223
Cash from Investing
-5
Cash from Financing
-221
-3
Free Cash Flow
204
OCF / Net Profit
0.77
Cumulative 5-Year FCF
0
OCF / Net Profit
0.77
Cumulative 5-Year FCF
0
Mar 2020
271
Cash from Investing
123
Cash from Financing
-335
60
Free Cash Flow
126
OCF / Net Profit
0.91
Cumulative 5-Year FCF
180
OCF / Net Profit
0.91
Cumulative 5-Year FCF
180
Mar 2021
375
Cash from Investing
-323
Cash from Financing
-82
-30
Free Cash Flow
353
OCF / Net Profit
1.06
Cumulative 5-Year FCF
422
OCF / Net Profit
1.06
Cumulative 5-Year FCF
422
Mar 2022
378
Cash from Investing
-320
Cash from Financing
-45
14
Free Cash Flow
268
OCF / Net Profit
0.93
Cumulative 5-Year FCF
621
OCF / Net Profit
0.93
Cumulative 5-Year FCF
621
Mar 2023
292
Cash from Investing
-982
Cash from Financing
688
-2
Free Cash Flow
-1,457
OCF / Net Profit
0.78
Cumulative 5-Year FCF
-506
OCF / Net Profit
0.78
Cumulative 5-Year FCF
-506
Mar 2024
486
Cash from Investing
-1,855
Cash from Financing
1,380
11
Free Cash Flow
-1,441
OCF / Net Profit
1.22
Cumulative 5-Year FCF
-2,150
OCF / Net Profit
1.22
Cumulative 5-Year FCF
-2,150
Mar 2025
1,065
Cash from Investing
-80
Cash from Financing
-881
104
Free Cash Flow
-271
OCF / Net Profit
2.84
Cumulative 5-Year FCF
-2,547
OCF / Net Profit
2.84
Cumulative 5-Year FCF
-2,547

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2016
EPS (₹)
9678.99
Book Value (₹)
21711.81
Dividend per Share (₹)
6042.00
Cash EPS (₹)
0.00
Operating Margin %
28.48%
Net Margin %
21.94%
ROE %
47.68%
ROCE %
54.56%
36.17%
Debtor Days
15
Inventory Days
31
Payable Days
114
-68
Debt to Equity (x)
0.00x
Interest Coverage (x)
558.56x
3.22x
Revenue Growth %
9.43%
Operating Profit Growth %
40.12%
Net Profit Growth %
51.09%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2017
EPS (₹)
17.95
Book Value (₹)
41.25
Dividend per Share (₹)
0.00
Cash EPS (₹)
19.59
Operating Margin %
39.26%
Net Margin %
32.90%
ROE %
56.90%
ROCE %
62.56%
43.89%
Debtor Days
18
Inventory Days
25
Payable Days
86
-43
Debt to Equity (x)
0.00x
Interest Coverage (x)
246.14x
2.08x
Revenue Growth %
25.54%
Operating Profit Growth %
68.07%
Net Profit Growth %
82.86%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2018
EPS (₹)
21.39
Book Value (₹)
62.64
Dividend per Share (₹)
0.00
Cash EPS (₹)
23.32
Operating Margin %
40.73%
Net Margin %
34.48%
ROE %
41.30%
ROCE %
35.76%
27.31%
Debtor Days
25
Inventory Days
26
Payable Days
167
-116
Debt to Equity (x)
0.44x
Interest Coverage (x)
30.31x
1.25x
Revenue Growth %
14.16%
Operating Profit Growth %
18.44%
Net Profit Growth %
19.61%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2019
EPS (₹)
21.15
Book Value (₹)
83.57
Dividend per Share (₹)
0.00
Cash EPS (₹)
23.81
Operating Margin %
38.36%
Net Margin %
29.64%
ROE %
28.96%
ROCE %
26.54%
20.02%
Debtor Days
28
Inventory Days
28
Payable Days
208
-152
Debt to Equity (x)
0.15x
Interest Coverage (x)
14.76x
1.73x
Revenue Growth %
14.79%
Operating Profit Growth %
8.11%
Net Profit Growth %
-1.30%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2020
EPS (₹)
21.84
Book Value (₹)
95.26
Dividend per Share (₹)
2.87
Cash EPS (₹)
25.54
Operating Margin %
35.74%
Net Margin %
27.61%
ROE %
24.28%
ROCE %
25.44%
20.33%
Debtor Days
41
Inventory Days
26
Payable Days
196
-129
Debt to Equity (x)
0.00x
Interest Coverage (x)
145.25x
2.43x
Revenue Growth %
9.36%
Operating Profit Growth %
1.89%
Net Profit Growth %
1.84%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2021
EPS (₹)
26.16
Book Value (₹)
115.81
Dividend per Share (₹)
5.50
Cash EPS (₹)
29.32
Operating Margin %
35.30%
Net Margin %
28.53%
ROE %
24.78%
ROCE %
27.60%
22.62%
Debtor Days
44
Inventory Days
24
Payable Days
155
-88
Debt to Equity (x)
0.00x
Interest Coverage (x)
200.75x
2.27x
Revenue Growth %
12.83%
Operating Profit Growth %
14.47%
Net Profit Growth %
19.77%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2022
EPS (₹)
29.88
Book Value (₹)
140.25
Dividend per Share (₹)
6.01
Cash EPS (₹)
34.61
Operating Margin %
36.64%
Net Margin %
29.09%
ROE %
23.33%
ROCE %
25.29%
21.27%
Debtor Days
39
Inventory Days
28
Payable Days
156
-88
Debt to Equity (x)
0.02x
Interest Coverage (x)
105.81x
2.51x
Revenue Growth %
11.15%
Operating Profit Growth %
16.31%
Net Profit Growth %
14.26%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2023
EPS (₹)
28.10
Book Value (₹)
161.28
Dividend per Share (₹)
7.35
Cash EPS (₹)
36.12
Operating Margin %
31.04%
Net Margin %
21.20%
ROE %
18.25%
ROCE %
17.30%
13.40%
Debtor Days
47
Inventory Days
26
Payable Days
126
-53
Debt to Equity (x)
0.38x
Interest Coverage (x)
16.46x
1.62x
Revenue Growth %
25.10%
Operating Profit Growth %
7.20%
Net Profit Growth %
-7.79%
0.00%
P/E (x)
0.00x
P/B (x)
0.00x
Dividend Yield %
0.00%
0.00x
Mar 2024
EPS (₹)
28.83
Book Value (₹)
189.79
Dividend per Share (₹)
0.00
Cash EPS (₹)
42.62
Operating Margin %
31.91%
Net Margin %
18.78%
ROE %
16.64%
ROCE %
12.37%
7.72%
Debtor Days
62
Inventory Days
28
Payable Days
165
-76
Debt to Equity (x)
1.06x
Interest Coverage (x)
6.09x
0.91x
Revenue Growth %
19.23%
Operating Profit Growth %
27.51%
Net Profit Growth %
6.14%
2.58%
P/E (x)
29.18x
P/B (x)
4.43x
Dividend Yield %
0.00%
18.29x
Mar 2025
EPS (₹)
25.83
Book Value (₹)
208.83
Dividend per Share (₹)
7.35
Cash EPS (₹)
50.67
Operating Margin %
34.22%
Net Margin %
12.61%
ROE %
13.81%
ROCE %
13.59%
5.48%
Debtor Days
54
Inventory Days
32
Payable Days
141
-55
Debt to Equity (x)
0.85x
Interest Coverage (x)
3.11x
0.89x
Revenue Growth %
44.02%
Operating Profit Growth %
48.22%
Net Profit Growth %
-5.65%
-10.39%
P/E (x)
54.83x
P/B (x)
6.78x
Dividend Yield %
0.52%
20.75x

Shareholding Pattern

Numbers in percentages

TRADES
Jun 2024
54.88
14.59
16.23
Government
0.00
14.30
Sep 2024
54.87
8.00
18.64
Government
0.00
18.47
Dec 2024
54.86
8.36
18.07
Government
0.00
18.72
Mar 2025
54.85
8.43
18.07
Government
0.00
18.66
Jun 2025
54.83
8.39
18.18
Government
0.00
18.59
Sep 2025
54.85
7.21
19.36
Government
0.00
18.57
Dec 2025
54.85
6.85
20.31
Government
0.00
17.99
Mar 2026
53.92
6.39
20.35
Government
0.00
19.33
Jun 2026
54.14
5.76
20.71
Government
0.00
19.40

Documents

Announcements

Credit Ratings

  • Credit Rating

    2026-05-08 - Eris Lifesciences Limited has informed the Exchange about Credit Rating

Concalls